Formulation of Employee Stock Purchase Scheme 2026
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Insecticides (India) Limited reported audited FY2026 standalone revenue of Rs 2,14,001 lakhs, a 7% increase from Rs 1,99,995 lakhs in FY2025. Profit after tax stood at Rs 13,973 lakhs with basic EPS of Rs 46.68. The Board approved the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme) allowing issuance of up to 2,00,000 equity shares (face value Rs 10) to employees with a 1-year lock-in period, subject to shareholder approval at the 29th AGM on August 12, 2026. Mrs. Nikunj Aggarwal resigned as Whole Time Director and Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for 5 years.
The ESPS scheme could help retain talent and align employee interests with shareholders. The resignation and appointment of directors indicates management transition within the Aggarwal family. Financial performance shows steady growth with revenue and profit improvements year-over-year.